Skip to main content
. 2015 Jul 21;6(28):24912–24921. doi: 10.18632/oncotarget.4701

Table 2. Univariate and multivariate analysis of different prognostic factors for 5-year survival in patients with NSCLC.

Varible Univariate analysis Multivariate analysis
HR P 95% CI HR P 95% CI
ROR2 expression 3.113 <0.001* 2.146–4.517 2.716 <0.001* 1.698–4.345
 High vs low
Wnt5a expression 2.500 <0.001* 1.759–3.553 1.774 0.003* 1.221–2.576
 High vs low
ROR2/Wnt5a expression 1.403 0.001* 1.158–1.701 0.924 0.569 0.704–1.213
 Both positive vs one positive vs both negative
Age(years) 1.040 0.830 0.730–1.481
 ≤ 60 vs > 60
Gender 0.931 0.730 0.621–1.396
 Male vs female
Differentiation 1.015 0.959 0.580–1.775
 Well and moderate vs poor
Histological type 1.157 0.149 0.949–1.411
 Sq vs Ad vs others
T 1.361 0.040* 1.015–1.827
 Tis+T1 vs T2 vs T3+T4
N 1.448 <0.001* 1.183–1.773
 N0 vs N1 vs N2
TNM stage 1.553 <0.001* 1.256–1.919 1.410 0.002* 1.133–1.755
 0-Ivs II vs III-IV
*

P < 0.05. TNM stage contains T stage and N stage, therefore, they were not included in the multivariate analysis.